Sharp Daily
No Result
View All Result
Wednesday, July 9, 2025
  • Home
  • News
    • Politics
  • Business
    • Banking
  • Investments
  • Technology
  • Startups
  • Real Estate
  • Features
  • Appointments
  • About Us
    • Meet The Team
Sharp Daily
  • Home
  • News
    • Politics
  • Business
    • Banking
  • Investments
  • Technology
  • Startups
  • Real Estate
  • Features
  • Appointments
  • About Us
    • Meet The Team
No Result
View All Result
Sharp Daily
No Result
View All Result
Home Opinion

Using technology to tackle Kenya’s counterfeit drug menace

Malcom Rutere by Malcom Rutere
June 18, 2025
in Opinion
Reading Time: 2 mins read

Kenya’s pharmaceutical sector faces a persistent and growing threat which is the circulation of counterfeit drugs. This crisis not only undermines the health of patients but also damages public confidence in the healthcare system and threatens national progress toward universal health coverage. The country’s regulatory efforts have yielded some progress, yet gaps in the supply chain, enforcement challenges, and limited consumer safeguards continue to allow fake drugs to reach patients. In this context, technology presents an essential set of tools that can help close these gaps and provide cost-effective, scalable solutions.

Counterfeit drugs represent a multi-billion shilling parallel economy. A report by the Pharmacy and Poisons Board indicates that 8.0% to 30.0% of medicine in circulation in Kenya may be counterfeit or expired. Drugs that are mainly counterfeited include antibiotics, painkillers and medications for diseases such as diabetes and hypertension. These drugs contain incorrect doses, harmful contaminants or no active ingredients at all. The health impacts include treatment failures, drug resistance, prolonged illness, and in some cases, death.

The technologies that can be used to address this crisis include mobile based drug verification which will enable patients to confirm whether a product is authentic before use. These systems work by printing a unique code on drug packaging that can be verified via SMS or QR code. Benefits derived from employing this strategy include its low costs and easy to deploy nationwide and real time response which empowers consumers directly. Second, blockchain offers an opportunity to digitize and secure the entire pharmaceutical supply chain. By creating a shared, decentralized ledger, every actor in the chain, from the manufacturer to the distributor, can track the movement of medicine in real time. Third, artificial intelligence can be applied to verify the physical characteristics of medicines such as label accuracy.

Despite the availability of various technologies, adoption in Kenya remains limited with major challenges including regulatory inertia with lack of policies mandating digital authentication. Second, cost barriers which is characterized by high costs of acquiring scanners and other technological infrastructure and limited public awareness where most consumers remain unaware of verification options. Strategic recommendations include regulatory mandates such as enforcing serialization and digital labelling for all drugs entering the Kenyan market and incorporating drug authentication in licensing and quality inspections and public-private partnerships which can be fostered by collaborating with mobile network operators and fintech platforms to integrate drug verification into health messaging.

RELATEDPOSTS

OPINION: How technology is shaping the future of Kenya’s property market

December 19, 2024

Harnessing technology to tackle Kenya’s youth joblessness

December 13, 2024

Kenya is at a pivotal moment in its fight against counterfeit drugs. The solutions are available, tested, and applicable at scale. By leveraging mobile technology, blockchain traceability, portable authentication tools, and AI, Kenya can restore trust in its pharmaceutical system, safeguard public health and set a continental example for innovation-driven healthcare safety.

Previous Post

A scalable solution to Kenya’s rural health crisis

Next Post

Why firms are shedding jobs despite survival

Malcom Rutere

Malcom Rutere

Related Posts

Economy

What happened to president Ruto’s economic dream?

June 27, 2025
Opinion

Opinion: Populism feeds votes, not growth

June 27, 2025
Opinion

Unlocking the power of REITs: A path for retail investors

June 26, 2025
Opinion

How Kenyan banks can bridge the cybersecurity talent gap

June 25, 2025
Opinion

How companies can prevent administration through early intervention

June 25, 2025
Opinion

How dormant assets could be a hidden economic engine

June 25, 2025

LATEST STORIES

How Kenya is future-proofing its economy against illicit finance

July 9, 2025

The importance of Investment Policy Statements (IPS) for pension schemes in Kenya

July 4, 2025

Understanding Life Cover as an Additional Benefit in Retirement Benefit Schemes

July 4, 2025

Del Monte foods files for bankruptcy in USA

July 3, 2025

Lessons from the Kuramo-TransCentury fallout

July 3, 2025

Private vs Public Pension Funds in Kenya

June 30, 2025

The mechanics of currency manipulation

June 27, 2025

Understanding how to access your pension savings in Kenya.

June 27, 2025
  • About Us
  • Meet The Team
  • Careers
  • Privacy Policy
  • Terms and Conditions
Email us: editor@thesharpdaily.com

Sharp Daily © 2024

No Result
View All Result
  • Home
  • News
    • Politics
  • Business
    • Banking
  • Investments
  • Technology
  • Startups
  • Real Estate
  • Features
  • Appointments
  • About Us
    • Meet The Team

Sharp Daily © 2024